目的 腹膜转移癌可以源自不同的原发性腹部肿瘤,肿瘤细胞减灭术联合腹腔热灌注化疗(cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy,CRS/HIPEC)治疗多种腹部肿瘤腹膜癌的预后存在明显的差异,本文将阐述CRS/HIPEC 治疗不同腹部肿瘤的疗效及安全性,并进一步分析影响CRS/HIPEC 治
Objective This study aimed to investigate the effect of NPTX1 on the prognosis of gastric cancer,as well as the underlying mechanisms in the process of metastatic in gastric cancer.